Why the study?
Cardiotoxicity is a significant adverse effect of cancer therapy, and early diagnosis of subclinical cardiac injury could allow cardioprotective therapy to prevent irreversible dysfunction and treatment interruptions.
Does two-dimensional speckle tracking echocardiography (2D-STE) beyond left ventricle global longitudinal strain improve the diagnosis of early subclinical cardiac injury in cancer patients?
Does two-dimensional speckle tracking echocardiography (2D-STE) beyond left ventricle global longitudinal strain improve the diagnosis of early subclinical cardiac injury in cancer patients?
This review highlights the potential of advanced 2D-STE parameters beyond standard LV GLS for the early detection of cardiotoxicity in cancer patients.
Answers are grounded in this paper and cite their sources.
2D-STE beyond LV GLS may aid early cardiotoxicity detection; leaves open prospective validation before clinical adoption.
With the improvement in survival rate, cardiotoxicity has emerged as a significant adverse effect of cancer therapy. Early diagnosis of subclinical cardiac injury may allow the initiation of cardioprotective therapy and preventing the interruption of optimal cancer therapy and the development of irreversible cardiac dysfunction. In this article, we review the role of two-dimensional speckle tracking echocardiography (2D-STE), beyond the common left ventricle global longitudinal strain in the diagnosis of early subclinical cardiac injury in patients treated with cancer therapies.
No takes yet. Share an insight, caveat, or question.
Laufer‐Perl et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: